| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 12,500 | $30 | $400K |
| J3262 | Injection, tocilizumab, 1 mg | 48,480 | $10 | $242.4K |
| J0897 | Injection, denosumab, 1 mg | 8,340 | $20 | $150.1K |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | 13,300 | $10 | $146.3K |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 2,170 | $30 | $56.4K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 500 | $60 | $30K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 310 | $100 | $29.4K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 160 | $90 | $14.2K |
| 96365 | The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease. | 250 | $50 | $11.3K |
| 99204 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider… | 80 | $110 | $8.2K |